Humana Inc. (NYSE: HUM) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 37.88 | EPS (ttm) | 10.56 | Insider Own | 0.52% | Shs Outstand | 120.08M | Perf Week | 1.30% |
| Market Cap | 48.03B | Forward P/E | 23.93 | EPS next Y | 16.72 | Insider Trans | 0.00% | Shs Float | 119.82M | Perf Month | 3.71% |
| Enterprise Value | 38.41B | PEG | 0.93 | EPS next Q | -1.00 | Inst Own | 74.98% | Short Float | 2.81% | Perf Quarter | 10.14% |
| Income | 1.28B | P/S | 0.33 | EPS this Y | -13.32% | Inst Trans | 0.00% | Short Ratio | 2.36 | Perf Half Y | 130.40% |
| Sales | 145.68B | P/B | 2.49 | EPS next Y | 82.63% | ROA | 2.23% | Short Interest | 3.36M | Perf YTD | 56.18% |
| Book/sh | 160.53 | P/C | 2.01 | EPS next 5Y | 40.61% | ROE | 6.91% | 52W High | 428.88 -6.73% | Perf Year | 28.88% |
| Cash/sh | 198.79 | P/FCF | - | EPS past 3/5Y | -23.62% -17.22% | ROIC | 4.52% | 52W Low | 163.11 145.25% | Perf 3Y | -13.15% |
| Dividend Est. | 3.54 (0.88%) | EV/EBITDA | 12.52 | Sales past 3/5Y | 11.75% 10.93% | Gross Margin | 13.65% | Volatility | 4.39% 3.41% | Perf 5Y | -1.33% |
| Dividend TTM | 3.54 (0.88%) | EV/Sales | 0.26 | EPS Y/Y TTM | 5.81% | Oper. Margin | 1.39% | ATR (14) | 14.62 | Perf 10Y | 126.09% |
| Dividend Ex-Date | Oct 30, 2026 | Quick Ratio | 1.74 | Sales Y/Y TTM | 23.65% | Profit Margin | 0.88% | RSI (14) | 57.72 | Recom | 2.66 |
| Dividend Gr. 3/5Y | 3.97% 7.20% | Current Ratio | 1.74 | EPS Q/Q | 21.37% | SMA20 | 2.54% | Beta | 0.74 | Target Price | 418.53 |
| Payout | 33.65% | Debt/Eq | 0.73 | Sales Q/Q | 26.18% | SMA50 | 2.84% | Rel Volume | 0.73 | Prev Close | 403.09 |
| Employees | 67,060 | LT Debt/Eq | 0.72 | Earnings | Nov 06 | SMA200 | 42.14% | Avg Volume | 1.33M | Price | 400.02 |
| IPO Date | Dec 31, 1981 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 4.70% 0.71% | Net Debt/EBITDA | 2.40 | Volume | 971,919 | Change | -0.76% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-24-26 | Reiterated | Wolfe Research | $450 | |
| Aug-05-26 | Upgrade | Morgan Stanley | Underweight → Equal Weight | $370 |
| Jul-31-26 | Reiterated | Barclays | Equal Weight | $344 → $407 |
| Jul-30-26 | Reiterated | Piper Sandler | Neutral | $254 → $463 |
| Jul-30-26 | Reiterated | Oppenheimer | Outperform | $340 → $405 |
| Jul-30-26 | Reiterated | Robert W. Baird | $205 → $390 | |
| Jul-30-26 | Reiterated | Leerink Partners | Market Perform | $255 → $513 |
| Jul-30-26 | Reiterated | UBS | Neutral | $320 → $405 |
| Jul-30-26 | Upgrade | Evercore ISI Group | In Line → Outperform | $480 |
| Jul-30-26 | Reiterated | Guggenheim | Buy | $269 → $471 |
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 145,679 | 129,664 | 117,811 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 125,789 | 110,812 | 100,664 | — | — | — | — | — | — | |
| Gross Profit | 19,890 | 18,852 | 17,147 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,978 | 0 | 0 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 13,890 | 17,399 | 15,520 | — | — | — | — | — | — | |
| Operating Income | 2,022 | 1,453 | 1,627 | — | — | — | — | — | — | |
| Interest Expense | 704 | 631 | 660 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 296 | 631 | 660 | — | — | — | — | — | — | |
| Net Income Before Taxes | 1,614 | 1,453 | 1,627 | — | — | — | — | — | — | |
| Income Taxes | 298 | 250 | 413 | — | — | — | — | — | — | |
| Consolidated Net Income | 1,278 | 1,188 | 1,207 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,316 | 1,203 | 1,214 | — | — | — | — | — | — | |
| Net Income | 1,278 | 1,188 | 1,207 | — | — | — | — | — | — | |
| EPS (Recurring) | 10.65 | 9.87 | 10.01 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 10.65 | 9.87 | 10.01 | — | — | — | — | — | — | |
| EPS (Diluted) | 10.56 | 9.84 | 9.98 | — | — | — | — | — | — | |
| EBITDA | 3,069 | 2,908 | 3,255 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 37.88 | 26.03 | 25.42 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.33 | 0.24 | 0.26 | — | — | — | — | — | — | |
| Gross Margin | 13.65 | 14.54 | 14.55 | — | — | — | — | — | — | |
| Operating Margin | 1.39 | 1.12 | 1.38 | — | — | — | — | — | — | |
| Net Margin | 0.88 | 0.92 | 1.02 | — | — | — | — | — | — | |
| Shares Outstanding | 120 | 120 | 121 | — | — | — | — | — | — | |
| Market Capitalization | 48,002 | 30,736 | 30,699 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Shetty Sanjay K | President, CenterWell | Apr 01 '26 | Option Exercise | 0.00 | 887 | 0 | 12,544 | Apr 03 |
| Renaudin George II | President, Insurance | Feb 24 '26 | Option Exercise | 0.00 | 1,035 | 0 | 16,494 | Feb 26 |
| Ventura Joseph C | Chief Legal Officer | Feb 24 '26 | Option Exercise | 0.00 | 1,035 | 0 | 17,565 | Feb 26 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Feb 24 '26 | Option Exercise | 0.00 | 165 | 0 | 7,568 | Feb 25 |
| Shetty Sanjay K | President, CenterWell | Feb 23 '26 | Buy | 185.21 | 810 | 150,016 | 11,657 | Feb 25 |
| Dintenfass David | President, Enterprise Growth | Feb 21 '26 | Option Exercise | 0.00 | 3,858 | 0 | 15,316 | Feb 24 |
| Mehta Japan | Chief Information Officer | Feb 13 '26 | Option Exercise | 0.00 | 1,682 | 0 | 8,158 | Feb 18 |
| Mellet Celeste | Chief Financial Officer | Feb 13 '26 | Option Exercise | 0.00 | 7,763 | 0 | 28,454 | Feb 18 |
| Rechtin James A. | President & CEO | Jan 08 '26 | Option Exercise | 0.00 | 2,183 | 0 | 29,285 | Jan 12 |
| O'Hara Michelle A. | Chief Human Resources Officer | Jan 01 '26 | Option Exercise | 0.00 | 2,353 | 0 | 10,634 | Jan 05 |
| Mellet Celeste | Chief Financial Officer | Dec 15 '25 | Option Exercise | 0.00 | 2,128 | 0 | 29,676 | Dec 17 |
| Mehta Japan | Chief Information Officer | Dec 15 '25 | Option Exercise | 0.00 | 1,194 | 0 | 8,628 | Dec 17 |
| Dintenfass David | President, Enterprise Growth | Dec 15 '25 | Option Exercise | 0.00 | 2,032 | 0 | 16,234 | Dec 17 |
| Shetty Sanjay K | President, CenterWell | Dec 15 '25 | Option Exercise | 0.00 | 2,276 | 0 | 11,566 | Dec 17 |
| O'Hara Michelle A. | Chief Human Resources Officer | Dec 15 '25 | Option Exercise | 0.00 | 1,401 | 0 | 11,266 | Dec 17 |